Brian S Gerstenberger

6PUBLICATIONS
31CO-AUTHORS
AllergyCheminformatics and quantitative structure-activity relationshipsComputational chemistryMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 10, 2026
Discovery of an ITK and TRK kinase inhibitor for the potential topical treatment of atopic dermatitis.

Jennifer L Duffen, Kimberly K Crouse, Lin Ji

|Sep 22, 2025
Discovery of PF-07054894, a Potent Squaramide-Based CCR6 Antagonist Displaying High CXCR2 Selectivity.

Mark E Schnute, Huixian Wu, John I Trujillo

|Feb 17, 2025
Conformational Role of Methyl in the Potency of Cyclohexane-Substituted Squaramide CCR6 Antagonists.

Brian S Gerstenberger, Ray Unwalla, Kathleen A Farley

|Aug 31, 2024
Structural basis for CCR6 modulation by allosteric antagonists.

David Jonathan Wasilko, Brian S Gerstenberger, Kathleen A Farley

|May 04, 2023
Therapeutics for COVID-19.

Sima S Toussi, Jennifer L Hammond, Brian S Gerstenberger

|Aug 14, 2020
Discovery of Tyrosine Kinase 2 (TYK2) Inhibitor (PF-06826647) for the Treatment of Autoimmune Diseases.

Brian S Gerstenberger, Catherine Ambler, Eric P Arnold

Pageof 1

Frequent Collaborators

3 joint publications

Mark E Schnute

3 joint publications

Andrew Flick

2 joint publications

James J Mousseau

2 joint publications

John I Trujillo